Nanomedicine Applied in the Control and Diagnosis of Viral Infections
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 8124
Special Issue Editors
Interests: viral vaccines; viral diagnostics; nanomaterials applied to viral biotechnologies
Special Issues, Collections and Topics in MDPI journals
Interests: vaccines; nanoparticles; arbovirus; diagnostic tests; adjuvant nanoparticles
Interests: arbovirus; viral diagnostics; nanomaterials applied to viral biotechnologies
Special Issue Information
Dear Colleagues,
Nanomedicine is a new and emerging subject of research that aims to develop innovative technologies to diagnose, treat or prevent diseases. Nanomedicine brings together pharmaceutical and biomedical sciences to produce nanoparticles able to deliver drugs and antigens, perform diagnosis, and also improve safety and toxicity. Nanoparticles can be used to develop new vaccines, diagnostic tests, and treatments for infectious diseases, and therefore, this approach could be a new alternative to solve important problems in diseases caused by viruses. Nanoparticles can have an intrinsic antiviral activity or improve the antiviral activity of some compounds, can be used as part of biosensors to detect the whole virus, viral antigens, or viral genome and also improve immune response triggered by vaccination. Recent advances in this area of research have shown the potential application of nanoparticle systems in the control and diagnosis of viral infections. Therefore, this Special Issue is focused on recent advances, methods, and approaches in preparing nanoparticles to treat (antiviral action), detect (diagnostic tests), and prevent (vaccines) viral diseases.
Prof. Dr. Flavio Guimaraes da Fonseca
Dr. Luiz Felipe Leomil Coelho
Dr. Breno de Mello Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Prof. Dr. Flavio Guimaraes da Fonseca
Dr. Luiz Felipe Leomil Coelho
Dr. Breno de Mello Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine for antiviral therapy
- nanomedicine for diagnostic of viral infections
- nanomedicine strategies for viral vaccine delivery
- nanoparticle-based biosensors for viral diagnosis
- virus-like particles and nanotechnology
- nanotechnology and viruses
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
